Cubist Systematic Strategies, LLC Catalent, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 7,800 shares of CTLT stock, worth $460,980. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,800

Previous 7,800 -0.0%

Holding current value

$460,980

Previous $438,000 7.76%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$42.56 - $59.82 $2.26 Million - $3.18 Million	53,182 New	53,182 $3 Million
Q2 2023 Aug 14, 2023	BUY	$31.86 - $67.26 $3.8 Million - $8.02 Million	119,304 New	119,304 $5.17 Million
Q4 2022 Feb 14, 2023	SELL	$41.39 - $81.0 $2.67 Million - $5.23 Million	-64,517 Reduced 88.7%	8,218 $369,000
Q3 2022 Nov 14, 2022	BUY	$72.36 - $113.1 $5.01 Million - $7.83 Million	69,249 Added 1986.49%	72,735 $5.26 Million
Q2 2022 Aug 15, 2022	SELL	$87.2 - $114.05 $1.25 Million - $1.64 Million	-14,383 Reduced 80.49%	3,486 $374,000
Q1 2022 May 16, 2022	SELL	$94.19 - $124.49 $358,298 - $473,559	-3,804 Reduced 17.55%	17,869 $1.98 Million
Q4 2021 Feb 14, 2022	BUY	$119.57 - $139.07 $1.64 Million - $1.91 Million	13,726 Added 172.72%	21,673 $2.78 Million
Q3 2021 Nov 15, 2021	SELL	$109.17 - $142.35 $1.67 Million - $2.17 Million	-15,257 Reduced 65.75%	7,947 $1.06 Million
Q2 2021 Aug 16, 2021	SELL	$100.34 - $115.69 $3.35 Million - $3.86 Million	-33,381 Reduced 58.99%	23,204 $2.51 Million
Q1 2021 May 17, 2021	SELL	$101.51 - $125.27 $834,006 - $1.03 Million	-8,216 Reduced 12.68%	56,585 $5.96 Million
Q4 2020 Feb 16, 2021	SELL	$85.88 - $105.36 $7.75 Million - $9.5 Million	-90,185 Reduced 58.19%	64,801 $6.74 Million
Q3 2020 Nov 16, 2020	BUY	$72.74 - $92.5 $8.06 Million - $10.2 Million	110,762 Added 250.46%	154,986 $13.3 Million
Q2 2020 Aug 14, 2020	BUY	$48.02 - $79.04 $1.68 Million - $2.76 Million	34,911 Added 374.86%	44,224 $3.24 Million
Q1 2020 May 15, 2020	BUY	$36.95 - $62.95 $344,115 - $586,253	9,313 New	9,313 $484,000
Q4 2019 Feb 14, 2020	SELL	$47.06 - $56.64 $8.29 Million - $9.98 Million	-176,252 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$47.45 - $58.05 $7.97 Million - $9.75 Million	168,014 Added 2039.5%	176,252 $8.4 Million
Q2 2019 Aug 14, 2019	SELL	$39.26 - $54.21 $1.63 Million - $2.26 Million	-41,614 Reduced 83.48%	8,238 $447,000
Q1 2019 May 15, 2019	SELL	$29.84 - $43.92 $1.45 Million - $2.13 Million	-48,554 Reduced 49.34%	49,852 $2.02 Million
Q4 2018 Feb 14, 2019	BUY	$29.95 - $46.34 $2.74 Million - $4.25 Million	91,640 Added 1354.42%	98,406 $3.07 Million
Q3 2018 Nov 14, 2018	SELL	$40.12 - $45.55 $5.85 Million - $6.64 Million	-145,825 Reduced 95.57%	6,766 $308,000
Q2 2018 Aug 14, 2018	BUY	$38.72 - $42.52 $5.12 Million - $5.63 Million	132,304 Added 652.16%	152,591 $6.39 Million
Q1 2018 May 15, 2018	SELL	$39.4 - $47.39 $535,052 - $643,556	-13,580 Reduced 40.1%	20,287 $833,000
Q4 2017 Feb 14, 2018	BUY	$37.27 - $43.02 $681,780 - $786,964	18,293 Added 117.46%	33,867 $1.39 Million
Q3 2017 Nov 14, 2017	BUY	$33.75 - $41.67 $525,622 - $648,968	15,574	15,574 $622,000

Others Institutions Holding CTLT

# of Institutions

512

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.6B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Catalent, Inc. Transaction History